MyAverix Finance
PA · Healthcare
Transgene SA (TNG)
Biotechnology
Transgene SA (TNG) is listed on PA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $230.10M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TNG
Transgene SA (TNG) — FAQ
What is Transgene SA's market cap?
Transgene SA (TNG) has a reported market cap of $230.10M (data as of 2026-05-24).
What is TNG's P/E ratio?
The price-to-earnings (P/E) ratio for Transgene SA (TNG) is 25.00 (data as of 2026-05-24).
Does Transgene SA pay a dividend?
Dividend yield is not available in the current snapshot for Transgene SA (TNG). Check the MyAverix Finance app for the latest dividend data.
What sector is Transgene SA in?
Transgene SA (TNG) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TNG listed on?
TNG is listed on PA.
What is Transgene SA's net margin?
Transgene SA (TNG) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.